
A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …

MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …

Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …

The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …

The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …

Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …

A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …

Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …

ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …

The EMA has judged that the benefits offered by Zinbryta (daclizumab), Abbvie and Biogen’s humanised IgG1 monoclonal antibody for the …

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …

The FDA has revealed its decision to approve AstraZeneca’s oral potassium-removing agent Lokelma (sodium zirconium cyclosilicate) for the treatment of …

Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians. The case has dominated …

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …